|
UBE2E1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.407800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.734000E-01 |
| Normal-vs-Stage2 |
1.353760E-01 |
| Normal-vs-Stage3 |
6.753200E-01 |
| Normal-vs-Stage4 |
4.779000E-01 |
| Stage1-vs-Stage2 |
9.319700E-02 |
| Stage1-vs-Stage3 |
6.374000E-01 |
| Stage1-vs-Stage4 |
4.585400E-01 |
| Stage2-vs-Stage3 |
2.312800E-01 |
| Stage2-vs-Stage4 |
4.405800E-01 |
| Stage3-vs-Stage4 |
7.290400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.951200E-01 |
| Normal-vs-AfricanAmerican |
4.553200E-01 |
| Normal-vs-Asian |
9.063000E-01 |
| Caucasian-vs-AfricanAmerican |
3.109800E-01 |
| Caucasian-vs-Asian |
5.957200E-01 |
| AfricanAmerican-vs-Asian |
5.487000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.765800E-01 |
| Normal-vs-Female |
5.432000E-01 |
| Male-vs-Female |
5.324200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.992000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.750800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.191030E-01 |
| Normal-vs-Age(81-100Yrs) |
9.776800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.571500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.186370E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.174400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.778200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.292200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.402400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.546400E-01 |
| Classical-VS-Follicular |
4.003700E-03 |
| Classical-VS-Other |
7.421200E-01 |
| Classical-VS-Normal |
7.050600E-01 |
| Tall-VS-Follicular |
2.571500E-02 |
| Tall-VS-Other |
9.590200E-01 |
| Tall-VS-Normal |
3.484200E-01 |
| Follicular-VS-Other |
2.411200E-01 |
| Follicular-VS-Normal |
3.970200E-02 |
| Other-VS-Normal |
5.958600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.177220E-01 |
| Normal-vs-N1 |
7.066600E-01 |
| N0-vs-N1 |
4.157800E-01 |
|
|
